3D Systems Names Claudia Napal Drayton to Board of Directors
02 Dezembro 2021 - 12:15PM
3D Systems (NYSE:DDD) today announced the appointment of Ms.
Claudia Napal Drayton to its Board of Directors, effective
immediately. Ms. Drayton currently serves as the Chief Financial
Officer of Quantum-Si (NASDAQ:QSI), a life sciences company focused
on technology related to protein sequencing and genomics for the
healthcare industry.
“We are delighted to welcome Claudia to our Board of Directors,”
said Chip McClure, chairman of the board of 3D Systems. “Her
outstanding career as a finance leader, in roles ranging from
public accounting to sophisticated medical devices and, in recent
years, biotech companies, will prove invaluable to both our Audit
Committee and our Board in general.”
In commenting on Ms. Drayton’s appointment, Dr. Jeffrey Graves,
president and chief executive officer of 3D Systems added, “Claudia
brings additional depth to our Board in key areas of healthcare and
biotechnology that will serve us well as we continue to accelerate
our efforts in medical devices, orthopedics and the increasingly
exciting new arena of regenerative medicine.”
Ms. Drayton began her career in public accounting with Arthur
Andersen and then moved to Medtronic, a global leader in medical
devices, where she held positions of increasing responsibility in
the finance organization over her 15-year tenure. These included
Chief Financial Officer for both the Peripheral Vascular and the
Integrated Health Solutions business units. In 2015, Ms. Drayton
left Medtronic to assume the role of Chief Financial Officer of
Nuwellis, and, more recently, of Quantum-Si, an emerging biotech
company. These leadership roles have provided tremendous exposure
to all aspects of a successful and disciplined healthcare business,
including international operations gained through her ex-patriot
assignment in Europe with Medtronic. As an active public company
CFO, Claudia is intimately familiar with all aspects of financial
controls and SEC reporting, as well as the unique requirements of
the global healthcare industry.
“It’s an honor to join the 3D Systems Board of Directors at this
point in the company’s transformation,” said Ms. Drayton.
“I’m excited about 3D Systems’ history of innovation, and the
success it has clearly demonstrated through its focus on the
healthcare industry. The potential for 3D printing in medical
device applications, as well as a tremendous range of biological
applications within the human body, offer outstanding opportunities
for growth and value creation as new solutions are brought to
patients in need around the world.”
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as "believes," "belief," "expects," "may,"
"will," "estimates," "intends," "anticipates" or "plans" or the
negative of these terms or other comparable terminology.
Forward-looking statements are based upon management’s beliefs,
assumptions, and current expectations and may include comments as
to the company’s beliefs and expectations as to future events and
trends affecting its business and are necessarily subject to
uncertainties, many of which are outside the control of the
company. The factors described under the headings "Forward-Looking
Statements" and "Risk Factors" in the company’s periodic filings
with the Securities and Exchange Commission, as well as other
factors, could cause actual results to differ materially from those
reflected or predicted in forward-looking statements. Although
management believes that the expectations reflected in the
forward-looking statements are reasonable, forward-looking
statements are not, and should not be relied upon as a guarantee of
future performance or results, nor will they necessarily prove to
be accurate indications of the times at which such performance or
results will be achieved. The forward-looking statements included
are made only as of the date of the statement. 3D Systems
undertakes no obligation to update or review any forward-looking
statements made by management or on its behalf, whether as a result
of future developments, subsequent events or circumstances or
otherwise.
About 3D Systems More than 30 years ago,
3D Systems brought the innovation of 3D printing to the
manufacturing industry. Today, as the leading Additive
Manufacturing solutions partner, we bring innovation, performance,
and reliability to every interaction - empowering our customers to
create products and business models never before possible. Thanks
to our unique offering of hardware, software, materials, and
services, each application-specific solution is powered by the
expertise of our application engineers who collaborate with
customers to transform how they deliver their products and
services. 3D Systems’ solutions address a variety of advanced
applications in healthcare and industrial markets such as medical
and dental, aerospace & defense, automotive, and durable goods.
More information on the company is available
at www.3dsystems.com.
Investor Contact:
investor.relations@3dsystems.comMedia
Contact: press@3dsystems.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/6b6b5817-8828-4aa5-bebd-299405138c00
3D Systems (NYSE:DDD)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
3D Systems (NYSE:DDD)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024